drugset / Trial / NCT03265951

Ramelteon for Complex Insomnia in Veterans With PTSD

NCT03265951

RandomizedParallel-groupDouble-blindTreatment

Summary

Obstructive sleep apnea is commonly reported in Veterans with post-traumatic stress disorder, which can potentiate symptoms of anxiety and depression, daytime symptoms and worsen nightmares. Continuous positive airway pressure is the most effective therapy but adherence to treatment is suboptimal. The overarching theme of the proposal is to compare usual care to Ramelteon, in a randomized, clinical trial, investigating the effectiveness of physiological versus pharmacological intervention on sleep quality of life, insomnia severity and CPAP adherence.

Timeline

Start
2018-01-01
Primary completion
2019-09-30
Completion
2020-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ramelteon Unknown 8 mg Oral

Indications